Abstract
The aim of this study was to systematically review articles that investigated the prognostic significance of different microRNAs in bladder cancer (BC). We systematically searched PubMed, Web of Science, and Embase to identify relevant studies until March 2016. After screening, 26 studies that involved 2753 patients were included. Results suggested that many miRs expression aberration may predict prognosis in patients with BC. There are six miRs (miR-21, miR-143, miR-155, miR-200, miR-214, and miR-222) were reported by at least two studies, and we performed meta-analysis in the corresponding studies. Accordingly, we found that high miR-21 expression was associated with poor overall survival [OS; hazard ratio (HR) = 3.94, 95% CI 2.08–7.44]. High miR-143 expression was associated with poor progression-free survival (PFS; HR = 3.78, 95% CI 1.61–8.89). High miR-155 expression was associated with poor PFS (HR = 8.10, 95% CI 2.92–22.48). High miR-222 expression was associated with poor OS (HR = 3.39, 95% CI 1.10–10.41). Meanwhile, low miR-214 expression was correlated with poor RFS(HR = 0.34, 95% CI 0.22–0.53). Our comprehensive systematic review concluded that microRNAs, particularly miR-21, miR-143, miR-155, miR-214, and miR-222, could serve as meticulous follow-up markers for early detection of progression or recurrence and even useful therapeutic targets for the treatment in patients with BC.
Highlights
The aim of this study was to systematically review articles that investigated the prognostic significance of different microRNAs in bladder cancer (BC)
12 articles evaluating the relationship between six specific miRs and BC prognosis satisfied the criteria for meta-analysis[14, 16, 18,19,20,21,22,23,24,25,26,27]
The results showed that high miR-21 expression was correlated with poor overall survival (OS) [a fixed-effect model, hazard ratio (HR), 3.94; 95% CI: 2.08–7.44; p < 0.001; I2 = 18.4%, p = 0.268]
Summary
The aim of this study was to systematically review articles that investigated the prognostic significance of different microRNAs in bladder cancer (BC). High miR-143 expression was associated with poor progression-free survival (PFS; HR = 3.78, 95% CI 1.61–8.89). MIBC, which could rapidly progress and metastasize, is correlated with a high mortality despite the improved therapeutic strategies at the moment[4]. In this regard, prediction models identifying patients with unfavorable prognosis, who may benefit from early systematic therapy, are greatly needed. We perform systematic review and meta-analysis to further increase statistical power, improve clinical translation, and comprehensively investigate the prognostic value of different miRs in patients with BC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.